DD137588A5 - Verfahren zur herstellung einer kristallform von 7-amino-thiazolyl-azetamidozephalosporansaeuresalzen - Google Patents

Verfahren zur herstellung einer kristallform von 7-amino-thiazolyl-azetamidozephalosporansaeuresalzen

Info

Publication number
DD137588A5
DD137588A5 DD78207090A DD20709078A DD137588A5 DD 137588 A5 DD137588 A5 DD 137588A5 DD 78207090 A DD78207090 A DD 78207090A DD 20709078 A DD20709078 A DD 20709078A DD 137588 A5 DD137588 A5 DD 137588A5
Authority
DD
German Democratic Republic
Prior art keywords
azetamidocephalosporansaeuresalces
thiazolyl
amino
preparing
crystal form
Prior art date
Application number
DD78207090A
Other languages
English (en)
Inventor
Gaston Amiard
Dieter Bormann
Walter Duerckheimer
Jean Jolly
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD137588(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DD137588A5 publication Critical patent/DD137588A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD78207090A 1977-08-17 1978-08-02 Verfahren zur herstellung einer kristallform von 7-amino-thiazolyl-azetamidozephalosporansaeuresalzen DD137588A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament

Publications (1)

Publication Number Publication Date
DD137588A5 true DD137588A5 (de) 1979-09-12

Family

ID=9194564

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78207090A DD137588A5 (de) 1977-08-17 1978-08-02 Verfahren zur herstellung einer kristallform von 7-amino-thiazolyl-azetamidozephalosporansaeuresalzen

Country Status (34)

Country Link
US (1) US4224371A (de)
EP (1) EP0001024B1 (de)
JP (1) JPS5441890A (de)
AT (2) AT366049B (de)
AU (1) AU520898B2 (de)
BG (2) BG33887A3 (de)
CA (1) CA1121343A (de)
CS (2) CS207646B2 (de)
DD (1) DD137588A5 (de)
DE (1) DE2860358D1 (de)
DK (2) DK152213C (de)
EG (1) EG13520A (de)
ES (1) ES472381A1 (de)
FI (1) FI65433C (de)
FR (1) FR2400519A1 (de)
GE (2) GEP19960476B (de)
GR (1) GR73661B (de)
HR (1) HRP931395B1 (de)
HU (1) HU181497B (de)
IE (1) IE47230B1 (de)
IL (1) IL55186A (de)
IT (1) IT1107961B (de)
MD (2) MD247C2 (de)
MX (2) MX155976A (de)
NO (1) NO156168C (de)
NZ (1) NZ188163A (de)
OA (1) OA06016A (de)
PL (1) PL126619B1 (de)
PT (1) PT68431A (de)
RO (1) RO79999A (de)
SI (1) SI7811917A8 (de)
SU (2) SU799666A3 (de)
YU (1) YU42166B (de)
ZA (1) ZA784187B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
WO1987001117A2 (en) * 1985-08-12 1987-02-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Also Published As

Publication number Publication date
CS207646B2 (en) 1981-08-31
PL126619B1 (en) 1983-08-31
BG33888A3 (en) 1983-05-16
NO782782L (no) 1979-02-20
OA06016A (fr) 1981-06-30
ATA52280A (de) 1981-07-15
FR2400519B1 (de) 1980-05-16
AT366050B (de) 1982-03-10
SU799666A3 (ru) 1981-01-23
EP0001024A1 (de) 1979-03-07
ATA563578A (de) 1981-07-15
JPS6145626B2 (de) 1986-10-08
FI782494A (fi) 1979-02-18
MX5448E (es) 1983-08-09
IL55186A0 (en) 1978-09-29
DK152213B (da) 1988-02-08
IL55186A (en) 1981-07-31
SU852175A3 (ru) 1981-07-30
DK361078A (da) 1979-02-18
MD225C2 (ro) 1995-12-31
CA1121343A (fr) 1982-04-06
MD225B1 (ro) 1995-06-30
CS207647B2 (en) 1981-08-31
YU191778A (en) 1983-02-28
US4224371A (en) 1980-09-23
HU181497B (en) 1983-07-28
GEP19960475B (en) 1996-07-22
FR2400519A1 (fr) 1979-03-16
EG13520A (en) 1982-03-31
GR73661B (de) 1984-03-28
ZA784187B (en) 1979-09-26
RO79999A (ro) 1982-10-11
GEP19960476B (en) 1996-07-22
MD247C2 (ro) 1995-12-31
NZ188163A (en) 1981-10-19
FI65433C (fi) 1984-05-10
MD247B1 (ro) 1995-07-31
DK163514C (da) 1992-07-27
SI7811917A8 (en) 1997-12-31
IE47230B1 (en) 1984-01-25
EP0001024B1 (de) 1981-01-21
YU42166B (en) 1988-06-30
IE781669L (en) 1979-02-17
DK159786D0 (da) 1986-04-09
IT1107961B (it) 1985-12-02
AU520898B2 (en) 1982-03-04
BG33887A3 (en) 1983-05-16
DK159786A (da) 1986-04-09
NO156168C (no) 1987-08-19
HRP931395B1 (en) 1996-04-30
ES472381A1 (es) 1979-03-16
NO156168B (no) 1987-04-27
IT7850648A0 (it) 1978-08-08
DE2860358D1 (en) 1981-03-12
DK163514B (da) 1992-03-09
FI65433B (fi) 1984-01-31
JPS5441890A (en) 1979-04-03
DK152213C (da) 1988-07-11
PL209080A1 (pl) 1979-06-04
MX155976A (es) 1988-06-06
AT366049B (de) 1982-03-10
AU3896578A (en) 1980-02-21
PT68431A (fr) 1978-09-01

Similar Documents

Publication Publication Date Title
DD137107A5 (de) Verfahren zur herstellung von spiro-hydantoinderivaten
DD135768A5 (de) Verfahren zur herstellung von guajaconsaeure a
DD135380A5 (de) Verfahren zur herstellung von 4-acylamino-phenyl-aethanolaminen
DD135500A5 (de) Verfahren zur herstellung von polyaetheramid-saeuren
DD137588A5 (de) Verfahren zur herstellung einer kristallform von 7-amino-thiazolyl-azetamidozephalosporansaeuresalzen
DD139256A5 (de) Verfahren zur herstellung von substituierten diaminoanthrachinonen
DD133803A1 (de) Verfahren zur herstellung von furokumarinen
DD135482A5 (de) Verfahren zur herstellung von p-benzochinon
DD134090A5 (de) Verfahren zur herstellung von pyridinylaminoalkylaether
DD138651A5 (de) Verfahren zur herstellung von alpha-fluormethyl-alpha-amino-alkansaeuren
DD137584A5 (de) Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten
ATA392577A (de) Verfahren zur herstellung von acylcyaniden
DD134089A5 (de) Verfahren zur herstellung von 4-diphenylmethylen-1-hydroxybenzylpiperidinen
DD130144A5 (de) Verfahren zur herstellung von benzoylcyanid
ATA392477A (de) Verfahren zur herstellung von acylcyaniden
DD131013A5 (de) Verfahren zur herstellung von alpha-ketocarbonsaeuren(b)
DD134100A5 (de) Verfahren zur herstellung von lactamen
DD138506A1 (de) Verfahren zur herstellung einer waessrigen loesung
LU78483A1 (de) Verfahren zur herstellung von benzoxazolyl-phenylstilbenen
DD139252A5 (de) Verfahren zur herstellung von alkylphenolen
DD134517A5 (de) Verfahren zur herstellung von p-nitroso-diphenylhydroxylaminen
DD135384A5 (de) Verfahren zur herstellung von 2-hydroxybenzthiazol-verbindungen
DD134524A5 (de) Verfahren zur herstellung von 1-oxadethiacephamverbindungen
DD135382A5 (de) Verfahren zur herstellung von triazolo-thieno-diazepin-1-onen
LU78135A1 (de) Verfahren zur herstellung von benzodifuranen